<html>
<head>PUBMED IDs for FBXO10</head>
<body bgcolor='#C5F0F2'><h1>FBXO10</h1><a href='https://pubmed.ncbi.nlm.nih.gov/23138933/'>Human MCS5A1 candidate breast cancer susceptibility gene FBXO10 is induced by cellular stress and correlated with lens epithelium-derived growth factor (LEDGF).</a> May 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23138928/'>Negative regulation of NEP expression by hypoxia.</a> June 29  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24008983/'>Differential 12-O-Tetradecanoylphorbol-13-acetate-induced activation of rat mammary carcinoma susceptibility Fbxo10 variant promoters via a PKC-AP1 pathway.</a> March 11  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24008976/'>PTGS1 compound heterozygosity impairs gene expression and platelet aggregation and is associated with severe bleeding complications.</a> July 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25786224/'>Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study.</a> February 26  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26187670/'>FBXO11 represses cellular response to hypoxia by destabilizing hypoxia-inducible factor-1Î± mRNA.</a> December 15  2015<br></body></html>
